banner
Doxorubicin agent, Xylan-PEG-doxorubicin, Purity ≥95%

Cat. No.: X25-05-YM1024

Doxorubicin agent, Xylan-PEG-doxorubicin, Purity ≥95%

Synonym: Xylan-PEG-doxorubicin; Doxorubicin-PEG-xylan

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Sub Cat. No. Molecular Weight Glycan Name Functional Group Inquiry
X25-05-YM1024-1 PEG 350 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-2 PEG 550 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-3 PEG 750 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-4 PEG 1 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-5 PEG 2 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-6 PEG 3 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-7 PEG 4 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-8 PEG 5 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-9 PEG 10 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-10 PEG 20 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-1 PEG 350 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-2 PEG 550 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-3 PEG 750 Da Xylan Doxorubicin Inquiry
X25-05-YM1024-4 PEG 1 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-5 PEG 2 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-6 PEG 3 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-7 PEG 4 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-8 PEG 5 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-9 PEG 10 kDa Xylan Doxorubicin Inquiry
X25-05-YM1024-10 PEG 20 kDa Xylan Doxorubicin Inquiry
Properties
Description
Xylan-PEG-doxorubicin constitutes a tripartite conjugate system developed to synergize xylan's ecologically derived architectural framework—composed of β-1,4-linked xylose residues harvested from vegetative hemicellulose materials—with doxorubicin's functional attributes through polyethylene glycol intermediation. The natural biopolymer matrix contributes hydration maintenance and surface adherence performance while improving biological material compatibility.
Molecular Formula
0
Glycan Structure
Its glycan structure is a linear backbone of β-1,4-linked D-xylose residues with side-chain substitutions including α-linked arabinofuranose, glucuronic acid/4-O-methyl-glucuronic acid, and acetyl groups at O-2 or O-3 positions.
Source
Chemical synthesis
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Xylan-PEG-doxorubicin can be used for its potential to develop anthracycline-loaded redox-sensitive carriers for tumor microenvironment targeting.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0